Key result
Antifibrinolytic drugs are being evaluated to quantify their efficacy in reducing blood loss, transfusion requirements, and mortality after acute traumatic injury.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
TXA may safely reduce mortality in bleeding trauma patients; leaves open effects in isolated TBI.
Roberts et al. (2011) studied this question. Antifibrinolytic drugs are being evaluated to quantify their efficacy in reducing blood loss, transfusion requirements, and mortality after acute traumatic injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: